During the past decade, Klinik Schillerhöhe conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinik Schillerhöhe" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "AIO-Studien-gGmbH" with 1 trials sponsored, "Chimerix" with 1 trials sponsored, "FibroGen" with 1 trials sponsored and "Hannover Medical School" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik Schillerhöhe" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "German Cancer Research Center" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Klinik Schillerhöhe" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Bacterial Pneumonia" (1 trials), "COVID-19" (1 trials), "Cancers With DNA Repair-Deficiency" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Klinik Schillerhöhe" in a lesser frequency.

Most popular intervention types in "Klinik Schillerhöhe" are "Drug" (8 trials), "Procedure" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (2 trials), "Carboplatin" (2 trials), "Lazertinib" (2 trials), "Placebo" (2 trials) and "Brigatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinik Schillerhöhe" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Klinik Schillerhöhe". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Klinik Schillerhöhe, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinik Schillerhöhe, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".